A Really Good Day, a memoir authored by Ayelet Waldman, is causing quite a stir from the time it was published back in 2017. In this book, the author shares her personal experience of how she micro-dosed on LSD in order to improve her mental health and also save her marriage that was on the verge of falling apart.
Micro-dosing involves taking one-tenth of the amount of LSD that recreational users take in order to “trip.” These micro-doses are taken at an interval of four days. The internet is awash with anecdotal reports of how people have benefitted from taking micro-doses of psychedelics, especially LSD. Waldman’s book has taken the discussion to a whole new level.
In that book, the author describes how she got hold of the LSD she used to get a huge transformation in her mental health. Having tried the existing conventional remedies for bipolar disorder, depression and premenstrual dysphoric disorder to no avail, she considered trying LSD.
Fortunately, an elderly acquaintance donated the last of his stash to her in an envelope signed by “Lewis Carroll.” Lewis Carroll wrote Alice in Wonderland, and the use of this name was alluding to the mental journey Waldman would experience once she used the LSD. The bottle Waldman received had enough LSD to last her a month.
In her book, Waldman recounts how all her symptoms “melted away” to such an extent that she was able to regain control of her life. Asked whether what she experienced wasn’t just a placebo effect, Waldman concurs that she has no proof a placebo effect wasn’t responsible for her transformation, but she hastens to add that if that were the case, it would be the greatest of all placebo effects.
Waldman is now a strong advocate for extensive research to be done into alternative remedies, including psychedelics, to treat mental health conditions. Her book brought her into contact with lots of people who were suffering under the yoke of the same conditions she has, and their despair that nothing currently seems to help pushed her into advocacy.
When her bottle of LSD was all used up, she didn’t replenish it and she says her mental health has taken a turn for the worse since then. She constantly struggles to maintain her equilibrium and hopes drug reform will take place at a faster rate so that people like her can access psychedelics legally and in a safe environment. She strongly believes that these powerful substances should only be administered under the watchful eye of a team of professionals who are capable of addressing any situation that may arise while a patient is under the influence of the psychedelic substance.
This cautious approach mirrors what psychedelics sector players like ATAI Life Sciences AG believe in, that psychedelics should only be administered in a clinical setting.
About PsychedelicNewsWire
PsychedelicNewsWire (PNW) is a specialized content distribution company that (1) aggregates and distributes news and information on the latest developments in all aspects and advances of psychedelics and their use, (2) creates PsychedelicNewsBreaks designed to quickly update investors on important industry news, (3) leverages a team of expert editors to enhance press releases for maximum impact, (4) assists companies with the management and optimization of social media across a range of platforms, and (5) delivers unparalleled corporate communication solutions. PNW stays abreast of the latest information and has established a reputation as the go to source for coverage of psychedelics, therapeutics and emerging market opportunities. Our team of seasoned journalists has a proven track record of helping both public and private companies gain traction with a wide audience of investors, consumers, media outlets and the general public by leveraging our expansive dissemination network of more than 5,000 key syndication outlets. PNW is committed to delivering improved visibility and brand recognition to companies operating in the emerging markets of psychedelics.
To receive instant SMS alerts, text “Groovy” to 21000 (U.S. Mobile Phones Only)
For more information please visit https://www.PsychedelicNewsWire.com
Please see full terms of use and disclaimers on the PsychedelicNewsWire website applicable to all content provided by PNW, wherever published or re-published: https://www.PsychedelicNewsWire.com/Disclaimer
Do you have questions or are you interested in working with PNW? Ask our Editor
PsychedelicNewsWire (PNW)
San Francisco, California
www.PsychedelicNewsWire.com
415.949.5050 Office
Editor@PsychedelicWire.com
PsychedelicNewsWire is part of the InvestorBrandNetwork.